Can GastroPanel be used as a triage tool to select patients with advanced atrophic gastritis for gastroscopy? A prospective clinical validation study
Objective Gastric adenocarcinoma (GAC) is the 17th most common cancer in the UK with a 5-year survival rate of 22%. GastroPanel (Biohit Oyj; Helsinki, Finland) is an ELISA kit that measures pepsinogen I (PGI); pepsinogen II (PGII); gastrin-17 (G-17); and Helicobacter pylori IgG antibodies (Hp IgG)....
Saved in:
Main Authors: | Eleanor Wood, Marco Novelli, Laura Marelli, Roger Feakins, Cinzia Papadia, Ray Shidrawi, Kari Juhani Syrjänen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | BMJ Open Gastroenterology |
Online Access: | https://bmjopengastro.bmj.com/content/12/1/e001559.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Detection Rate of Helicobacter Pylori Infection and Atrophic Gastritis Using Serological Markers “GastroPanel®” Among Employees of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
by: A. D. Kaprin, et al.
Published: (2024-05-01) -
Gastric Polyps and Atrophic Gastritis
by: I. Yu. Kolesnikova, et al.
Published: (2021-06-01) -
Serum Prohepcidin Levels Are Lower in Patients with Atrophic Gastritis
by: Hyung-Keun Kim, et al.
Published: (2013-01-01) -
Extensive Atrophic Gastritis Increases Intraduodenal Hydrogen Gas
by: Yoshihisa Urita, et al.
Published: (2008-01-01) -
Endoscopic and clinical characteristics of autoimmune atrophic gastritis: Retrospective study
by: Kareem Khalaf, et al.
Published: (2025-01-01)